As Trumps Ups The Ante On Tariffs, Reactions Are Mixed
Biotech Traded Higher, While Some Pharma Firms Fell
The US stock market broadly declined following increased tariffs on goods from China and new tariffs on goods from Mexico and Canada, but biopharma initially weathered the storm, while pharma faced some headwinds.
